systemic juvenile idiopathic arthritis
GPTKB entity
Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Actemra
|
| gptkbp:affects |
gptkb:Person
|
| gptkbp:associated_with |
autoimmune disorders
|
| gptkbp:caused_by |
inflammation
|
| gptkbp:clinical_trial |
patient quality of life
new medications treatment protocols |
| gptkbp:complications |
osteoporosis
joint damage growth problems |
| gptkbp:current_use |
uveitis
macrophage activation syndrome |
| gptkbp:future_plans |
variable
chronic symptoms potential remission |
| gptkbp:gender |
more common in boys
|
| gptkbp:historical_context |
first described in 1980s
previously known as Still's disease |
| https://www.w3.org/2000/01/rdf-schema#label |
systemic juvenile idiopathic arthritis
|
| gptkbp:is_a_route_for |
immune system dysregulation
increased cytokine production joint synovial inflammation |
| gptkbp:is_involved_in |
local organizations
online communities available for families |
| gptkbp:is_popular_in |
rare
|
| gptkbp:manager |
nutritional support
physical therapy occupational therapy |
| gptkbp:premiered_on |
before age 16
|
| gptkbp:research_focus |
genetic factors
environmental triggers biologic therapies |
| gptkbp:social_responsibility |
blood tests
imaging studies clinical evaluation depends on treatment response depends on early diagnosis affects 1 in 100,000 children depends on disease severity |
| gptkbp:symptoms |
fever
swelling rash joint pain |
| gptkbp:treatment |
corticosteroids
nonsteroidal anti-inflammatory drugs disease-modifying antirheumatic drugs |